CliffBio
small molecule

OLYSIO

SIMEPREVIR SODIUM

Loss of exclusivitySeptember 2029latest FDA-listed patent expiry
CompanyJANSSEN PRODUCTS LP

Drug detail

Brand nameOLYSIO
Active ingredientSIMEPREVIR SODIUM
StrengthEQ 150MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2013
Marketing statusDISCN

Listed patents

PatentExpiresType
8148399September 2029substance, product
8754106July 2026substance
8741926July 2026substance
9040562July 2026substance, product
9856265July 2026substance, product
9353103July 2026use U-1467
8349869July 2026substance, product
9623022July 2026use U-1467

More from JANSSEN PRODUCTS LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.